A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30825
Abstract: A surge of vascular endothelial growth factor (VEGF) after transarterial chemoembolization (TACE) may contribute to tumor progression. Axitinib is a potent antiangiogenic agent with main activity against VEGF receptors 1 to 3. To the authors'… read more here.
Keywords: hepatocellular carcinoma; combination; treatment; inoperable hepatocellular ... See more keywords
Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first‐line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study
Sign Up to like & getrecommendations! Published in 2021 at "Cancer"
DOI: 10.1002/cncr.33677
Abstract: The efficacy and safety of transarterial chemoembolization (TACE) plus lenvatinib in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT) have not been evaluated. read more here.
Keywords: hepatocellular carcinoma; portal vein; chemoembolization plus; transarterial chemoembolization ... See more keywords
Are prophylactic antibiotics necessary prior to transarterial chemoembolization for hepatocellular carcinoma in patients with native biliary anatomy?
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24993
Abstract: Prophylactic antibiotics are frequently administered for transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC). In patients without previous biliary instrumentation, infection risk from TACE is low. We hypothesized that there is a negligible rate of infection… read more here.
Keywords: hepatocellular carcinoma; prophylactic antibiotics; transarterial chemoembolization; anatomy ... See more keywords
Mineralized Supramolecular Microspheres with Immunoregulating Functions for Transarterial Chemoembolization Immunotherapy of Hepatocellular Carcinoma.
Sign Up to like & getrecommendations! Published in 2025 at "Small methods"
DOI: 10.1002/smtd.202500857
Abstract: Transcatheter arterial chemoembolization (TACE) is a pivotal therapeutic option for hepatocellular carcinoma (HCC) at intermediate or advanced stage. However, conventional TACE, which primarily relies on embolic microspheres for localized chemotherapy, suffers from limitations such as… read more here.
Keywords: tace; immunotherapy; transarterial chemoembolization; hepatocellular carcinoma ... See more keywords
Role of preoperative transarterial chemoembolization (TACE) in intermediate‐stage hepatocellular carcinoma (Hong Kong liver cancer stage IIB)
Sign Up to like & getrecommendations! Published in 2024 at "World Journal of Surgery"
DOI: 10.1002/wjs.12420
Abstract: Abstract Introduction Transarterial chemoembolization (TACE) has an established role in advanced HCC. The present study evaluates the role of TACE as a neoadjuvant modality in the management of intermediate HCC [Hong Kong Liver Cancer (HKLC)… read more here.
Keywords: tace; role; intermediate stage; stage ... See more keywords
Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology"
DOI: 10.1002/wnan.1749
Abstract: Transarterial chemoembolization (TACE) is a recommended treatment for patients suffering from intermediate and advanced hepatocellular carcinoma (HCC). As compared to the conventional TACE, drug-eluting bead TACE demonstrates several advantages in terms of survival, treatment response,… read more here.
Keywords: hepatocellular carcinoma; microspheres nanoparticles; advances applications; applications microspheres ... See more keywords
Transarterial chemoembolization combined with radiofrequency ablation for solitary large hepatocellular carcinoma ranging from 5 to 7 cm: an 8-year prospective study
Sign Up to like & getrecommendations! Published in 2020 at "Abdominal Radiology"
DOI: 10.1007/s00261-020-02612-5
Abstract: Purpose This prospective study was performed to investigate long-term (8-year) survival in patients with solitary large hepatocellular carcinoma (HCC) ranging from 5 to 7 cm who underwent transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) and… read more here.
Keywords: hepatocellular carcinoma; solitary large; year; transarterial chemoembolization ... See more keywords
Transarterial Chemoembolization with Doxorubicin Eluting Beads for Extra-Abdominal Desmoid Tumors: Initial Experience
Sign Up to like & getrecommendations! Published in 2022 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-022-03149-4
Abstract: To evaluate the feasibility, efficacy, and safety of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) as an alternative local treatment for extra-abdominal desmoid tumors (DTs). Eleven adult female patients (mean age = 40.1 years) with symptomatic, progressively enlarging extra-abdominal… read more here.
Keywords: transarterial chemoembolization; doxorubicin eluting; desmoid tumors; extra abdominal ... See more keywords
Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-024-05722-5
Abstract: Transarterial chemoembolization (TACE) has become the standard of care for the treatment of intermediate-stage hepatocellular carcinoma (HCC). However, current clinical practice guidelines lack consensus on the best selection of a specific TACE technique. This study… read more here.
Keywords: dsm; tace; deb tace; response ... See more keywords
Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection
Sign Up to like & getrecommendations! Published in 2019 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-019-05733-0
Abstract: Background There is lack of data for identifying optimal local therapy for the management of recurrent hepatocellular carcinoma (HCC) after hepatic resection. Aims A retrospective study was performed to compare the effectiveness of transarterial chemoembolization… read more here.
Keywords: hepatocellular carcinoma; recurrent hepatocellular; tace; group ... See more keywords
Reproducibility of mRECIST in Measurement and Response Assessment for Hepatocellular Carcinoma Treated by Transarterial Chemoembolization.
Sign Up to like & getrecommendations! Published in 2018 at "Academic radiology"
DOI: 10.1016/j.acra.2018.02.013
Abstract: RATIONALE AND OBJECTIVES To evaluate the reproducibility of Modified Response Evaluation Criteria in Solid Tumors (mRECIST) for hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) using multiphasic computed tomography. MATERIALS AND METHODS The institutional review board… read more here.
Keywords: hepatocellular carcinoma; tace; response; reproducibility ... See more keywords